MHC Class II Deficiency with Normal CD4+ T Cell Counts: A Case Report

被引:0
作者
Abolnezhadian, Farhad [1 ]
Saieedi-Boroujen, Ali [2 ,3 ,4 ]
Iranparast, Sara [2 ,3 ]
机构
[1] Ahvaz Jundishapur Univ Med Sci, Abuzar Childrens Hosp, Dept Pediat, Ahvaz, Iran
[2] Ahvaz Jundishapur Univ Med Sci, Student Res Comm, Ahvaz, Iran
[3] Ahvaz Jundishapur Univ Med Sci, Dept Immunol, Ahvaz, Iran
[4] Abadan Sch Med Sci, Abadan, Iran
关键词
Genetic diseases; Human; Immunologic deficiency syndromes; Inborn; Molecular sequence data RFXANK protein; TRANSPLANTATION; IMMUNODEFICIENCY; SURVIVAL; DISEASE;
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Major histocompatibility complex (MHC) class II deficiency is a rare primary immunodeficiency disorder (PID) with less than 200 cases worldwide. Here, we report an 8 month-old girl with MHC class II deficiency with a novel homozygous mutation in RFXANK gene (NM_001278728: exon 5: c.495G>A: p.Trp165*) and normal CD4(+) T cell counts, diagnosed by whole exome sequencing (WES) and negative HLA-DR proteins on peripheral blood mononuclear cell (PBMC) in flow cytometry. She was referred with pneumonia, prolonged fever, resistance to antibiotics (ceftriaxone, clindamycin, and vancomycin), and low serum immunoglobulin (IG) levels, while natural killer (NK), B, and T cells were normal. She received intra-venous immune-globulin (IVIG) replacement, broad spectrum antibiotics, and anti-fungal treatments. The presented case report is interesting not only because of the rarity of the PID but also due to normal CD4(+) T cell counts. According to our experience, we suggest that physicians consider MHC class II deficiency in families with consanguineous marriages, even with normal CD4(+) T cell counts. At the first, the diagnosis of the disease could be successfully perform using WES, and finally, treatment with hematopoietic stem cell transplantation can save the patients' lives.
引用
收藏
页码:594 / 600
页数:7
相关论文
共 18 条
  • [1] Primary immunodeficiency Diseases in Highly Consanguineous Populations from Middle east and north Africa: epidemiology, Diagnosis, and Care
    Al-Mousa, Hamoud
    Al-Saud, Bandar
    [J]. FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [2] Allogeneic Stem Cell Transplantation Using Myeloablative and Reduced-Intensity Conditioning in Patients with Major Histocompatibility Complex Class II Deficiency
    Al-Mousa, Hamoud
    Al-Shammari, Zamil
    Al-Ghonaium, Abdulaziz
    Al-Dhekri, Hasan
    Al-Muhsen, Saleh
    Al-Saud, Bander
    Arnaout, Rand
    Al-Seraihy, Amal
    Al-Jefri, Abdullah
    Al-Ahmari, Ali
    Ayas, Mouhab
    El-Solh, Hassan
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (06) : 818 - 823
  • [3] Alyasin S, 2015, IRAN J IMMUNOL, V12, P219, DOI IJIv12i3A7
  • [4] Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies:: report of the European experience 1968-99
    Antoine, C
    Müller, S
    Cant, A
    Cavazzana-Calvo, M
    Veys, P
    Vossen, J
    Fasth, A
    Heilmann, C
    Wulffraat, N
    Seger, R
    Blanche, S
    Friedrich, W
    Abinun, M
    Davies, G
    Bredius, R
    Schulz, A
    Landais, P
    Fischer, A
    [J]. LANCET, 2003, 361 (9357) : 553 - 560
  • [5] Clinical, Immunological and Genetic Findings of a Large Tunisian Series of Major Histocompatibility Complex Class II Deficiency Patients
    Ben-Mustapha, Imen
    Ben-Farhat, Khaoula
    Guirat-Dhouib, Naouel
    Dhemaied, Emna
    Largueche, Beya
    Ben-Ali, Meriem
    Chemli, Jalel
    Bouguila, Jihene
    Ben-Mansour, Lamia
    Mellouli, Fethi
    Khemiri, Monia
    Bejaoui, Mohamed
    Barbouche, Mohamed-Ridha
    [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 2013, 33 (04) : 865 - 870
  • [6] Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4+25+ immunoregulatory T cells
    Bensinger, SJ
    Bandeira, A
    Jordan, MS
    Caton, AJ
    Laufer, TM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (04) : 427 - 438
  • [7] Clinical, immunological and genetic features in eleven Algerian patients with major histocompatibility complex class II expression deficiency
    Djidjik, Reda
    Messaoudani, Nesrine
    Tahiat, Azzedine
    Meddour, Yanis
    Chaib, Samia
    Atek, Aziz
    Khiari, Mohammed Elmokhtar
    Benhalla, Nafissa Keltoum
    Smati, Leila
    Bensenouci, Abdelatif
    Baghriche, Mourad
    Ghaffor, Mohammed
    [J]. ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2012, 8
  • [8] MHC class II deficiency: Report of a novel mutation and special review
    Farrokhi, S.
    Shabani, M.
    Aryan, Z.
    Zoghi, S.
    Krolo, A.
    Bortug, K.
    Rezaei, N.
    [J]. ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2018, 46 (03) : 263 - 275
  • [9] KLEIN C, 1995, BLOOD, V85, P580
  • [10] The 752delG26 mutation in the RFXANK gene associated with major histocompatibility complex class II deficiency: evidence for a founder effect in the Moroccan population
    Naamane, Hamid
    El Maataoui, Ouafaa
    Ailal, Fatima
    Barakat, Abdelhamid
    Bennani, Siham
    Najib, Jilali
    Hassar, Mohammed
    Saile, Rachid
    Bousfiha, Ahmed Aziz
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 2010, 169 (09) : 1069 - 1074